Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:26:21.707Z.
Calculation as of: 2026-10-06T18:26:21.707Z.
Quote observation: 2026-10-06T18:07:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$44.54M
EV/FCF Ratio
13.17x
TTM Avg
37.31x
3Y Avg
6410.23x
5Y Avg
6410.23x
Market Cap
$43.31M
EV/FCF Ratio
N/A
TTM Avg
16.14x
3Y Avg
18.58x
5Y Avg
128.19x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $44.27M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.18M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.40M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.54M | 13.17x | 37.31x | 6410.23x | 6410.23x |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.44M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.31M | N/A | 16.14x | 18.58x | 128.19x |
| Precipio, Inc. (PRPO)vs › | $42.15M | 53.75x | 75.69x | 62.69x | 62.69x |
| Veru Inc. (VERU)vs › | $41.30M | N/A | 6831.21x | 6831.21x | 3431.14x |
| Instil Bio, Inc. (TIL)vs › | $47.41M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute